Goal Directed Fluid Therapy during pancreaticoduodenectomy operatio
Not Applicable
Recruiting
- Conditions
- Surgeryobservation during surgery
- Registration Number
- PACTR201801002862138
- Lead Sponsor
- national liver institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
¿Adults scheduled for elective Whipple operations.
¿ASA classification I and II.
Exclusion Criteria
¿Cardiac co-morbidity.
¿Severe coagulation disorder
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie stroke volume variation in pancreaticoduodenectomy fluid management?
How does goal-directed fluid therapy using stroke volume variation compare to CVP in postoperative outcomes for pancreatic cancer patients?
Are there specific biomarkers that predict response to goal-directed fluid therapy in pancreaticoduodenectomy procedures?
What are the potential adverse events associated with stroke volume variation monitoring during major abdominal surgeries?
How does the PACTR201801002862138 trial contribute to optimizing hemodynamic management in perioperative pancreatic surgery?